The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis

Published:2022-09 Issue:9 Volume:7 Page:851-861
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Riazi Kiarash,Azhari Hassan,Charette Jacob H,Underwood Fox E,King James A,Afshar Elnaz Ehteshami,Swain Mark G,Congly Stephen E,Kaplan Gilaad G,Shaheen Abdel-Aziz

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference59 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases;Chalasani;Hepatology,2018

2. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Nonalcoholic fatty liver disease and liver transplantation - where do we stand?;Mikolasevic;World J Gastroenterol,2018

4. Dietary patterns and components in nonalcoholic fatty liver disease (NAFLD): what key messages can health care providers offer?;Riazi;Nutrients,2019

5. Case-finding strategies in non-alcoholic fatty liver disease;Boursier;JHEP Rep,2020

Cited by 927 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanism of epigallocatechin gallate in treating non-alcoholic fatty liver disease: Insights from network pharmacology and experimental validation;Biochemical and Biophysical Research Communications;2024-11

2. Caffeic acid ameliorates metabolic dysfunction-associated steatotic liver disease via alleviating oxidative damage and lipid accumulation in hepatocytes through activating Nrf2 via targeting Keap1;Free Radical Biology and Medicine;2024-11

3. Comparative genomic and metabolomic analysis reveals the potential of a newly isolated Enterococcus faecium B6 involved in lipogenic effects;Gene;2024-11

4. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

5. A preclinical model of severe NASH-like liver injury by chronic administration of a high-fat and high-sucrose diet in mice;Toxicology and Applied Pharmacology;2024-10